Ikofficial Ikofficial
Search Results
See All Results
  • Join
    Sign In
    Sign Up
    Search
    Night Mode

Search

Discover new people, create new connections and make new friends

  • News Feed
  • EXPLORE
  • Pages
  • Groups
  • Events
  • Blogs
  • Offers
  • Jobs
  • Courses
  • Forums
  • Posts
  • Blogs
  • Users
  • Pages
  • Groups
  • Events
  • Anjali Shinde added blog Health
    2026-07-07 06:57:51 -
    Targeted Radionuclide Therapy Market Outlook: Advancing Precision Cancer Treatment
    The Targeted Radionuclide Therapy Market is witnessing a transformative era, driven by the urgent need for more effective, personalized cancer treatments. Unlike traditional chemotherapy or external beam radiation, this therapeutic approach delivers radioactive isotopes directly to tumor cells with high precision, minimizing damage to surrounding healthy tissue. As the prevalence of complex...
    0 Comments 0 Shares 140 Views 0 Reviews
    Please log in to like, share and comment!
  • Subhayan Mayra added blog Other
    2026-04-22 10:25:47 -
    Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034
    According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...
    0 Comments 0 Shares 2K Views 0 Reviews
    Please log in to like, share and comment!
  • Subhayan Mayra added blog Other
    2026-06-19 11:00:30 -
    Global Dual-Antibody ADC Market Growing at 6.2% CAGR Through 2032
    According to a new report from Intel Market Research, the global Dual-Antibody ADC market was valued at USD 477 million in 2024 and is projected to reach USD 691 million by 2032, exhibiting a steady CAGR of 6.2% during the forecast period (2025–2032). This growth is driven by increasing cancer prevalence and demand for precision medicine, superior tumor targeting capabilities of...
    0 Comments 0 Shares 674 Views 0 Reviews
    Please log in to like, share and comment!
  • Subhayan Mayra added blog Other
    2026-04-20 11:24:05 -
    Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034
    According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...
    0 Comments 0 Shares 1K Views 0 Reviews
    Please log in to like, share and comment!
  • Subhayan Mayra added blog Other
    2026-04-22 10:39:42 -
    TKIs for Breast Cancer Market Growing at 7.3% CAGR Through 2034
    According to a new report from Intel Market Research, the global TKIs for Breast Cancer market was valued at USD 1.82 billion in 2025 and is projected to reach USD 3.74 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025–2034). This growth is propelled by the rising global incidence of breast cancer, growing adoption of precision oncology, and increasing regulatory...
    0 Comments 0 Shares 1K Views 0 Reviews
    Please log in to like, share and comment!
  • Subhayan Mayra added blog Other
    2026-06-12 10:21:20 -
    United States ADC for Solid Tumors Market Growing at 8.9% CAGR Through 2034
    The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...
    0 Comments 0 Shares 743 Views 0 Reviews
    Please log in to like, share and comment!
© 2026 Ikofficial English
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Terms Privacy Contact Us Directory